Effects of Angiotensin Converting Enzyme Inhibitors on Thrombotic Mediators: Potential Clinical Implications

Author： Kothari Seema A.   Le Mytrang K.   Gandhi Pritesh J.  

Publisher： Springer Publishing Company

ISSN： 0929-5305

Source： Journal of Thrombosis and Thrombolysis, Vol.15, Iss.3, 2003-06, pp. : 217-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Angiotensin-converting enzyme inhibitors: ischemia is not the correct measure of benefit

By Anderson H.V.  

Journal of the American College of Cardiology, Vol. 42, Iss. 12, 2003-12 ,pp. : 2060-2062

Elsevier

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitor on Delayed-Onset Doxorubicin-Induced Cardiotoxicity

By Boucek Robert J.   Steele Ann   Miracle Ann   Atkinson James  

Cardiovascular Toxicology, Vol. 3, Iss. 4, 2003-12 ,pp. : 319-330

Humana Press, Inc

Access to resources Recommend Favorite

Effects of Angiotensin-Converting Enzyme Inhibitory Peptide LAP on Vascular Remodeling

By Huang Junling   Luo Ming   Fang Hong   Zheng Huan   Shen Yi   Li Lingxia   Deng Yuqing   Xu Huifeng  

Clinical and Experimental Hypertension, Vol. 35, Iss. 6, 2013-10 ,pp. : 437-443

Informa Healthcare

Access to resources Recommend Favorite

The appropriate dose of angiotensin‐converting‐enzyme inhibitors or angiotensin receptor blockers in patients with dilated cardiomyopathy. The higher, the better?

By  

ESC HEART FAILURE, Vol. 2, Iss. 4, 2015-12 ,pp. : 103-105

John Wiley & Sons Inc

Access to resources Recommend Favorite

Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Treatment of Hypertension: Should they be Used Together?

By  

Current Vascular Pharmacology, Vol. 8, Iss. 6, 2010-11 ,pp. : 742-746

Bentham Science Publishers

Access to resources Recommend Favorite